Apta Biosciences has sold its IP and is no longer operating. Apta developed a proprietary, groundbreaking method for creating synthetic alternatives to antibodies, a core component of medical diagnostics and therapeutics. The company was a spin-out from Fujitsu, where the technology was originally developed.
| Website | http://www.aptabiosciences.com |
| Revenue | $3 million |
| Employees | 1 (1 on RocketReach) |
| Founded | 2013 |
| Technologies | |
| Industry | Biotechnology, Pharmaceuticals, Biotechnology Research, Science and Engineering, Healthcare, Health Diagnostics, Health Care |
| Keywords | Biotechnology, Medical Diagnostics, Therapeutics, Diagnostic Tools, Drug Development, Pharmaceutical Research, Life Sciences, Biomarkers, Biosensors, Precision Medicine, Protein Engineering, Molecular Diagnostics, In-Vitro Diagnostics, Therapeutic Antibodies, Clinical Diagnostics, Biomedical Research |
| Competitors | Thermo Fisher Scientific, Merck Group, Bio-Rad Laboratories, Illumina, Agilent Technologies, Waters Corporation, Abbott, GE HealthCare, PerkinElmer, Inc., Roche +40 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies |
Looking for a particular Apta Biosciences Ltd employee's phone or email?
Apta Biosciences Ltd Questions
The Apta Biosciences Ltd annual revenue was $3 million in 2026.
1 people are employed at Apta Biosciences Ltd.
The NAICS codes for Apta Biosciences Ltd are [5417, 54, 541].
The SIC codes for Apta Biosciences Ltd are [283, 28].
Related Companies
